Active Pharmaceutical Ingredients Market is Estimated to Value Over USD 240.1 Billion by 2026 End

  • 16 Oct 2019

Global Active Pharmaceutical Ingredient Market is estimated to value over USD 240.1 billion by 2026 end and register a CAGR of over 5.9% during the forecast period 2019 to 2026.

The active pharmaceutical ingredients market is projected to see sizeable growth owing to the ever increasing presence of infectious diseases, cardiovascular ailments and a number of other chronic disorders. Another factor that can be attributed to the global active pharmaceutical ingredients market growth is the push for more biomedical innovations by various government and healthcare sectors on a global scale. This is why the global healthcare system has undertaken certain measures of using biosimilar, as it is a more budget-friendly alternative. Biosimilar allows for a sustainable healthcare framework and creates greater scope for innovations, thereby, allowing a greater number of patients to receive optimum care and even goes as far as to treat diseases beyond the capacity of small molecular drugs.

In accordance with the market research, a number of developing nations have adopted generic drugs is expected to capture considerable global active pharmaceutical ingredients market share. Widespread usage of specialty drugs is projected to grow the pharmaceutical investment on a global scale, along with speedy growth in developed regions as opposed to their emerging counterparts. This can be attributed to the fact that developed nations hold higher capital margins, advanced manufacturing facilities, and place a strong importance on the idea of transparent pricing by analyzing the measuring impacts on the population.

By prioritizing commercialization of drugs and allowing for the massive reduction of operating costs by way of the outsourcing research and development activities, companies can enhance organizational productivity and efficiency on a large scale. If, at later stages of development, companies had to start outsourcing through the adoption of strategic partners, then it can boost operational efficiencies within the value chain. Furthermore, systematic linkages in the supply chain can provide substantial market share in diverse regions over the course of the forecast time frame.

Healthcare spending has seen consistent growth. Despite the fact that the proportion of healthcare expenditure in the region of the Asia Pacific region is considerably low, the growth rate in this region has shown a great deal of potential and has outperformed even that of mature and well-established markets in the regions of Europe and North America. The hike in the healthcare expenditure has resulted in exceptional healthcare standards, thereby, making it widely accessible and boosting the need for pharmaceutical goods across Asia Pacific. The pharmaceuticals consumed here are primarily produced internationally. In addition, manufacturing units which specialize in contracts have emerged as major outsourcing allies for pharmaceutical companies which supply their materials to regions such as Europe and North America


Some major global players in the APIs market include Sanofi (France), Teva Pharmaceutical Industries Ltd. (Israel), AbbVie Inc. (US), Pfizer, Inc. (US), Boehringer Ingelheim (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Merck & Co., Inc. (US), Bristol-Myers Squibb (US), AstraZeneca plc (UK), Eli Lilly and Company (US).


Active Pharmaceutical Ingredient Market Segmentation:

By Type   

  • Innovative Active Pharmaceutical Ingredients
  •  Generic Active Pharmaceutical Ingredients 

By Type of Manufacturer

  • Captive API Manufacturers
  • Merchant API Manufacturers

 By Type

~ Merchant Innovative API Manufacturers

~ Merchant Generic API Manufacturers                

           By Type of Synthesis

 ~ Merchant Synthetic API Manufacturers

~ Merchant Biotech API Manufacturers

By Type of Synthesis

  • Synthetic Active Pharmaceutical Ingredients

- Innovative Synthetic APIS

- Generic Synthetic APIS        

  • Biotech Active Pharmaceutical Ingredients

           By Type

~  Innovative Biotech APIS

~  Generic Biotech APIS  

           By Product

~  Monoclonal Antibodies

~  Hormones & Growth Factors

~  Cytokines

~  Fusion Proteins

~  Recombinant Vaccines

~  Therapeutic Enzymes

~  Blood Factors

By Expression System

~ Mammalian Expression Systems

~ Microbial Expression Systems

~ Yeast Expression Systems

~ Insect Expression Systems

~ Other Expression Systems

By Type of Drug

  •   Prescription Drugs
  •   Over-The-Counter Drugs

By Potency

  •     Low-To-Moderate Potency Active Pharmaceutical Ingredients
  •     Potent-To-Highly Potent Active Pharmaceutical Ingredients

By Therapeutic Application

  •    Communicable Diseases
  •    Oncology  
  •    Pain Management
  •    Cardiovascular Diseases
  •    Diabetes
  •    Respiratory Diseases
  •    Other Therapeutic Applications

By Region                                                                            

  • North America
  • Europe
  • Asia-Pacific
  • World    


FutureWise Key Takeaways:

  •     Growth prospects
  •     SWOT analysis
  •     Key trends
  •     Key data-points affecting market growth


Objectives of the Study:

  • To provide with an exhaustive analysis on the active pharmaceuticals market by type, by manufacturer, by type of synthesis, by product, by type of drug, by potency, by therapeutic application and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, industry-specific restraints and opportunities)
  • To forecast and evaluate micro-markets and the overall market 
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and the rest of the world 
  • To record, evaluate and analyse competitive landscape mapping- technological advancements, product launches, expansions and mergers 


Get unlimited analyst support and customise this study further to your requirements, contact